(HYRM) DBX Trust - Ratings and Ratios
High-Yield Bonds, Cash Equivalents, Fixed Income Securities
Description: HYRM DBX Trust
The DBX ETF Trust, traded as HYRM on NYSE ARCA, is designed to mirror the performance of the U.S. dollar-denominated high yield corporate bond market under normal conditions. During adverse market conditions, it shifts focus to a USD cash position that accrues interest at the Effective Federal Funds Rate, providing a buffer against market volatility.
The fund adheres to its investment strategy by allocating at least 80% of its total assets to securities and instruments that replicate the index it tracks, or invests in alternatives that have similar economic characteristics. This approach ensures that the funds performance closely aligns with its underlying index, providing investors with the desired exposure to the high yield corporate bond market.
As a High Yield Bond ETF, HYRM offers investors a diversified portfolio of high yield, U.S. dollar-denominated corporate bonds. High yield bonds are typically issued by companies with lower credit ratings, offering higher yields to compensate for the increased risk. This category of ETFs is attractive to investors seeking higher income, albeit with a higher risk profile.
Analyzing the technical data, HYRMs last price is $23.15, slightly above its SMA20 of $22.99, indicating a positive short-term trend. The SMA50 and SMA200 are $23.10 and $23.08, respectively, suggesting a stable long-term trend. The ATR of 0.11, or 0.48%, indicates relatively low volatility. Given the 52-week high and low of $23.59 and $21.60, the current price is near its 52-week high, suggesting a strong performance over the past year.
Considering the fundamental data, the AUM of $45.26M USD indicates a relatively small but still viable fund. The size of the fund can impact its liquidity and trading costs.
Forecasting HYRMs performance, based on its technical and fundamental data, the ETF is likely to continue its stable trend. The proximity to its 52-week high and stable moving averages suggest that HYRM may consolidate around its current price or see a slight increase if the high yield corporate bond market remains favorable. However, any adverse market conditions could lead to a shift towards the USD cash position, potentially stabilizing the funds value. Investors should monitor the Effective Federal Funds Rate and overall market conditions to gauge the funds future performance.
Additional Sources for HYRM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HYRM ETF Overview
Market Cap in USD | 46m |
Category | High Yield Bond |
TER | 0.30% |
IPO / Inception | 2022-02-09 |
HYRM ETF Ratings
Growth Rating | 47.0 |
Fundamental | - |
Dividend Rating | 73.8 |
Rel. Strength | 6.05 |
Analysts | - |
Fair Price Momentum | 23.52 USD |
Fair Price DCF | - |
HYRM Dividends
Dividend Yield 12m | 5.50% |
Yield on Cost 5y | 6.25% |
Annual Growth 5y | 11.50% |
Payout Consistency | 100.0% |
Payout Ratio | % |
HYRM Growth Ratios
Growth Correlation 3m | 70.3% |
Growth Correlation 12m | 65.1% |
Growth Correlation 5y | 87.6% |
CAGR 5y | 4.20% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.13 |
Alpha | 1.84 |
Beta | 0.189 |
Volatility | 4.81% |
Current Volume | 6.5k |
Average Volume 20d | 1.2k |
As of July 01, 2025, the stock is trading at USD 23.50 with a total of 6,490 shares traded.
Over the past week, the price has changed by +0.76%, over one month by +1.72%, over three months by +1.20% and over the past year by +8.14%.
Partly, yes. Based on ValueRay´s Analyses, DBX Trust (NYSE ARCA:HYRM) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 46.96 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HYRM is around 23.52 USD . This means that HYRM is currently overvalued and has a potential downside of 0.09%.
DBX Trust has no consensus analysts rating.
According to our own proprietary Forecast Model, HYRM DBX Trust will be worth about 25.6 in July 2026. The stock is currently trading at 23.50. This means that the stock has a potential upside of +9.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.6 | 9.1% |